ARA-290 is an erythropoietin derivative with pronounced anti—inflammatory and neuroprotective effects. It binds to the IRR receptor (innate reper receptor), activating regeneration mechanisms without affecting erythropoiesis. Improves microcirculation, reduces vascular permeability and restores the barrier functions of the endothelium.
It is especially effective in neuropathic pain, vascular disorders and diabetic neuropathy. ARA-290 helps reduce peripheral inflammation and relieves pain without causing dependence or sedation.
Raw MaterialUSA
Country of OriginUAE
Purity99%
Raw MaterialUSA
Purity99%
Country of OriginUAE
Indications
Diabetic neuropathy
Chronic pain and neuroinflammation
Chronic Fatigue syndrome
Recovery from vascular and neurological disorders
Support of vascular health in anti-aging program
Contraindications
Pregnancy and lactation
Oncological diseases
Active autoimmune processes (in consultation with a doctor)
Acute infections
Individual intolerance
2 000 AED
Get consultation
ARA-290 is a selective non-erythropoietic peptide engineered to activate the EPOR–CD131 receptor complex, a key regulator of anti-inflammatory, neuroprotective, and reparative pathways — without stimulating erythropoiesis. Through...
ARA-290 is a selective non-erythropoietic peptide engineered to activate the EPOR–CD131 receptor complex, a key regulator of anti-inflammatory, neuroprotective, and reparative pathways — without stimulating erythropoiesis. Through this mechanism, the peptide promotes endothelial restoration, reduces neuroinflammation, enhances microcirculation, and supports the functional recovery of peripheral nerve fibers.
ARA-290 modulates immune mediator activity, protects tissues under metabolic and stress-related load, and accelerates cellular repair. Clinical data indicate that ARA-290 may reduce neuropathic pain by 30–40%, improve tissue sensitivity, and increase nerve-conduction velocity, making it a valuable component of modern neuroregenerative programs.
The pen format ensures precise delivery and stable bioavailability in protocols targeting nerve recovery, inflammation control, and endothelial protection.
Key Properties & Effects of ARA-290
• reduces peripheral neuroinflammation by activating EPOR–CD131
• improves microcirculation and restores endothelial function
• decreases neuropathic pain and enhances tissue sensitivity
• supports peripheral nerve regeneration
• reduces oxidative stress and cellular injury
• improves nerve-conduction speed and accelerates functional recovery
Why Choose ARA-290
• acts on core reparative and anti-inflammatory pathways
• suitable for patients with neuropathic symptoms of various origins
• provides a consistent and predictable therapeutic response
• safe profile: no impact on erythropoiesis, hormones, or stimulation pathways
• combines effectively with MOTS-c, NAD+, FST, and neuroprotective protocols
ARA-290 Pen is ideal for individuals requiring nervous-system support, inflammation reduction, improved microcirculation, and restoration of sensory function. It is used in neuroprotection programs, recovery protocols following nerve strain or injury, peripheral conduction-support schemes, and strategies for managing neuropathic discomfort. The format helps accelerate tissue recovery, reduce pain, and enhance overall quality of life.